{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:23:26Z","timestamp":1788175406630,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jcrc.2026.155489","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:37:15Z","timestamp":1771997835000},"page":"155489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Thromboelastography to monitor anticoagulation in ICU patients receiving a continuous infusion of unfractionated heparin"],"prefix":"10.1016","volume":"93","author":[{"given":"Sofia","family":"Spano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maninder","family":"Randhawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Hikasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuttapol","family":"Pattamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuanprae","family":"Kitisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"N\u00fcbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Caroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Eastwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Warrillow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ary Serpa","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis","family":"Chaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcrc.2026.155489_bb0005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/aor.14104","article-title":"Conventional versus restricted anti-Xa-guided heparin protocol in adult patients undergoing extracorporeal membrane oxygenation","volume":"46","author":"Alkazemi","year":"2022","journal-title":"Artif Organs"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155489_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1871529X19666190626124057","article-title":"Bivalirudin versus heparin during intervention in acute coronary syndrome: a systematic review of randomized trials","volume":"20","author":"Bhogal","year":"2020","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"issue":"2","key":"10.1016\/j.jcrc.2026.155489_bb0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.amjcard.2003.09.054","article-title":"Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation","volume":"93","author":"Fanikos","year":"2004","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.jcrc.2026.155489_bb0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/FJC.0000000000001608","article-title":"Low-intensity heparin infusion compared with high-intensity heparin infusion dosing in patients with mechanical mitral valves: a retrospective cohort study","volume":"84","author":"Olsen","year":"2024","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155489_bb0025","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.annemergmed.2024.05.009","article-title":"Trends in initial anticoagulation among US patients hospitalized with acute pulmonary embolism 2011-2020","volume":"84","author":"Westafer","year":"2024","journal-title":"Ann Emerg Med"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155489_bb0030","article-title":"Bleeding and thrombotic risk in low dose heparin infusion as compared to standard dose heparin infusion","volume":"12","author":"Lutfi","year":"2020","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.jcrc.2026.155489_bb0035","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1080\/14656566.2024.2364057","article-title":"Clinical guidance for unfractionated heparin dosing and monitoring in critically ill patients","volume":"25","author":"Samimi","year":"2024","journal-title":"Expert Opin Pharmacother"},{"issue":"8 Pt 2","key":"10.1016\/j.jcrc.2026.155489_bb0040","first-page":"108S","article-title":"Challenges in variation and responsiveness of unfractionated heparin","volume":"24","author":"Francis","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155489_bb0045","first-page":"547","article-title":"Monitoring unfractionated heparin with the aPTT: time for a fresh look","volume":"96","author":"Eikelboom","year":"2006","journal-title":"Thromb Haemost"},{"issue":"7\u20138","key":"10.1016\/j.jcrc.2026.155489_bb0050","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1345\/aph.1Q161","article-title":"Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion","volume":"45","author":"Guervil","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.jcrc.2026.155489_bb0055","first-page":"255","article-title":"A comparison of anti-coagulation monitoring tests in ICU patients receiving a continuous infusion of unfractionated heparin","volume":"26","author":"Spano","year":"2024","journal-title":"Crit Care Resusc"},{"issue":"19","key":"10.1016\/j.jcrc.2026.155489_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911219","article-title":"Anticoagulation monitoring with activated partial thromboplastin time and anti-Xa activity in intensive care unit patients: interest of thrombin generation assay","volume":"23","author":"Billoir","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jcrc.2026.155489_bb0065","first-page":"305","article-title":"Accuracy of aPTT monitoring in critically ill patients treated with unfractionated heparin","volume":"72","author":"van Roessel","year":"2014","journal-title":"Neth J Med"},{"issue":"2","key":"10.1016\/j.jcrc.2026.155489_bb0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ajh.23599","article-title":"TEG and ROTEM: technology and clinical applications","volume":"89","author":"Whiting","year":"2014","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.jcrc.2026.155489_bb0075","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/hq0701.093686","article-title":"Mechanism of action and pharmacology of unfractionated heparin","volume":"21","author":"Hirsh","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155489_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ajcp\/aqae088","article-title":"TEG(R) 6s coagulation testing with a novel heparin neutralization cartridge: technical validation and determination of normal reference ranges","volume":"163","author":"Hartmann","year":"2025","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.jcrc.2026.155489_bb0085","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1055\/s-0039-1696658","article-title":"Cartridge-based thromboelastography can be used to monitor and quantify the activity of unfractionated and low-molecular-weight heparins","volume":"3","author":"Dias","year":"2019","journal-title":"TH Open"},{"issue":"2","key":"10.1016\/j.jcrc.2026.155489_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.mbc.0000203859.62739.25","article-title":"The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays","volume":"17","author":"Coppell","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"10.1016\/j.jcrc.2026.155489_bb0095","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s13253-022-00507-0","article-title":"Coefficients of determination for mixed-effects models","volume":"27","author":"Zhang","year":"2022","journal-title":"J Agric Biol Environ Stat"},{"issue":"4","key":"10.1016\/j.jcrc.2026.155489_bb0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1037\/h0026256","article-title":"Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit","volume":"70","author":"Cohen","year":"1968","journal-title":"Psychol Bull"},{"issue":"1","key":"10.1016\/j.jcrc.2026.155489_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educ Psychol Meas"},{"issue":"3","key":"10.1016\/j.jcrc.2026.155489_bb0110","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155489_bb0115","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/CCM.0000000000004246","article-title":"Development and reporting of prediction models: guidance for authors from editors of respiratory, sleep, and critical care journals","volume":"48","author":"Leisman","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2026.155489_bb0120","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.21105\/joss.03167","article-title":"Visualizations with statistical details: the \u2018ggstatsplot\u2019 approach","volume":"6","author":"Patil","year":"2021","journal-title":"J Open Source Softw"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155489_bb0125","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/jcpt.12415","article-title":"Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study","volume":"41","author":"Samuel","year":"2016","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"10.1016\/j.jcrc.2026.155489_bb0130","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.chest.2021.09.024","article-title":"Study of alteplase for respiratory failure in SARS-CoV-2 COVID-19: a vanguard multicenter, rapidly adaptive, pragmatic, randomized controlled trial","volume":"161","author":"Barrett","year":"2022","journal-title":"Chest"},{"issue":"3 Suppl","key":"10.1016\/j.jcrc.2026.155489_bb0135","doi-asserted-by":"crossref","first-page":"188S","DOI":"10.1378\/chest.126.3_suppl.188S","article-title":"Heparin and low-molecular-weight heparin: the seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Hirsh","year":"2004","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jcrc.2026.155489_bb0140","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth Analg"},{"issue":"8","key":"10.1016\/j.jcrc.2026.155489_bb0145","first-page":"1015","article-title":"Revisiting the pharmacology of unfractionated heparin","volume":"58","author":"Derbalah","year":"2019","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"10.1016\/j.jcrc.2026.155489_bb0150","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/phar.2829","article-title":"Correlation between heparin anti-Xa activity and thromboelastography in adult critically ill COVID-19 patients","volume":"43","author":"Buckley","year":"2023","journal-title":"Pharmacotherapy"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944126000675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944126000675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:12:39Z","timestamp":1788174759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944126000675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"alternative-id":["S0883944126000675"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2026.155489","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thromboelastography to monitor anticoagulation in ICU patients receiving a continuous infusion of unfractionated heparin","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2026.155489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155489"}}